In re Sichert’s Empirical Analysis
566 F.2d 1154 · 1977
Citation profile
1 district ·
How this case has been cited
Cited by 15 later decisions — most recently April 1999
1 district ·
Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.
Relationships
Applies 21 U.S.C. § 372 (Federal Food, Drug, and Cosmetic Act) · 35 U.S.C. § 101 · 35 U.S.C. § 102 · 35 U.S.C. § 112
Relies on In re Wiechert · In re Wertheim · Application of Joseph D. Fisher · In re Marzocchi · In re Lukach
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 15 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“Congress has given the responsibility to the FDA, not to the [PTO], to determine ... whether drugs are sufficiently safe....”
1 later decision quote this exact passagee.g. Scott v. Finney
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.